Incidencia del uso de medicamentos que se encuentran fuera del cuadro nacional básico de medicamentos en el área de hospitalización - consulta externa en el Hospital Pediátrico Alfonso Villlagómez Román de Riobamba en el período mayo-agosto 2013

Abstract

The research was conducted at the Alfonso Villagómez Román Pediatric Hospital in Riobamba. The objective was to verify the incidence of the use of medicines that are not included in the Basic National Chart in the Hospitalization and Outpatient areas. The deductive method demonstrated the characterization of the epidemiological profile of the study population; the archived documents and statistical data allow establishing prevalent diseases, inpatient and outpatient consultations, prescribed drugs and pharmacological treatments. According to the results, 233 patients aged 1 to 8 years participated, allergic rhinitis was the most frequent pathology (30.4%); acute rhinopharyngitis (18%) and in readmission, infectious enteritis (39%); treatment time varied from 5 days to 3 or 6 months depending on the patient's metabolism and evolution; allergic rhinitis was 3 months. We conclude that Montelukast prevents respiratory distress, chest tightness, cough causing asthma; prevention of bronchospasm, symptoms of seasonal and permanent allergic rhinitis. Montelukast belongs to the leukotriene receptor antagonist drugs. It is recommended that montelukast be included in the basic drug list because of its greater efficiency and efficacy in the treatment of diseases of higher incidence and metamizol, cetirizine, tramadol, ambroxol, cefuroxime for diseases of lower incidence in order to guarantee access to low-income users.